0R2M.L

Regeneron Pharmaceuticals, Inc.
LSEUSDEQUITY DELAYED
Last price
842.87
▲ 8.43 (1.01%)
MARKET ·

Price

1D H L Range Vol
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
836.64
Prev close
834.44
Day high
850.00
Day low
815.55
Volume
206
Market cap
P/E (TTM)
0.12
52W range
689.00 – 998.57

Day trading desk

Current session · delayed
Gap from prior close
VWAP
839.81
+0.36% from price
Relative volume
0.11×
Quiet session
Session range
4.22%
815.55 – 850.00
Position in range
79%
Near session high
ATR (14D)
Daily true range
Prior day high
PDH
Prior day low
PDL
Bid / ask spread
Quote not published
Session volume
212
Avg 1.96K

VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

5 more panels on 0R2M.L open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Insider net activity

6m · Form 4 rollup
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
Net transactions
0
Buys less sells
Sell : buy shares
Not enough filings
Insider-held shares
2.08M
Total on file

Insider transactions

Account required
DateInsiderAction SharesValueHeld
Aug 10, 26
GUARINI KATHRYN PH.D.
Director
SELL 400 $320.00K Direct
Aug 10, 26
ZOGHBI HUDA Y
Director
SELL 800 $640.00K Direct
Aug 10, 26
GUARINI KATHRYN PH.D.
Director
CONVERSION 400 $287.75K Direct
Aug 10, 26
ZOGHBI HUDA Y
Director
CONVERSION 800 $301.35K Direct
Jul 2, 26
RYAN ARTHUR F.
Director
SELL 200 $130.03K Direct
May 1, 26
RYAN ARTHUR F.
Director
SELL 100 $70.52K Direct
Apr 1, 26
RYAN ARTHUR F.
Director
SELL 100 $77.73K Direct
Mar 2, 26
RYAN ARTHUR F.
Director
SELL 100 $78.55K Direct
Feb 19, 26
ZOGHBI HUDA Y
Director
SELL 1.64K $1.28M Direct
Feb 19, 26
ZOGHBI HUDA Y
Director
CONVERSION 1.64K $617.02K Direct
Feb 9, 26
PITOFSKY JASON
Officer
SELL 2.04K $1.59M Direct
Feb 9, 26
RYAN ARTHUR F.
Director
SELL 100 $77.85K Direct
Feb 9, 26
PITOFSKY JASON
Officer
CONVERSION 1.00K $492.00K Direct
Jan 7, 26
BASSLER BONNIE L
Director
SELL 1.50K $1.20M Direct
What this is, and what it is not

These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.

A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.

This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.

Free account required

Officer and director trades in their own stock, straight from Form 4 filings.

Insider holders

10 reporting
NameRelationShares heldLatest
BROWN MICHAEL S
Director 12.87K Stock Award(Grant)
FENIMORE CHRISTOPHER R
Chief Financial Officer 21.80K Stock Award(Grant)
LAROSA JOSEPH J
General Counsel 42.31K Stock Award(Grant)
MCCOURT MARION E
Officer 15.57K Stock Award(Grant)
MURPHY ANDREW J
Officer 56.44K Stock Award(Grant)
RYAN ARTHUR F.
Director 17.30K Sale
SCHLEIFER LEONARD S
Chief Executive Officer 687.98K Conversion of Exercise of derivative security
SING GEORGE LOUIS
Director 33.16K Stock Award(Grant)
VAN PLEW DANIEL P
Officer 37.73K Stock Award(Grant)
YANCOPOULOS GEORGE D
President 1.13M Conversion of Exercise of derivative security

Fundamentals

TTM · reported
Market cap
Enterprise value$78.36B
Revenue (TTM)$15.53B
Gross profit$6.91B
EBITDA$4.70B
Net income$4.33B
EPS (TTM)$70.31
Free cash flow$3.07B
Total cash$7.99B
Total debt$2.71B
Book value / share$316.11
Shares outstanding108.03M
Float95.79M
Short % of float
Dividend yield
Beta (5Y)0.19

Valuation & profitability ratios

Account required
Trailing P/E0.12
Forward P/E
PEG ratio
Price / sales
Price / book2.65
EV / revenue5.04
EV / EBITDA16.66
Gross margin44.46%
Operating margin33.11%
Profit margin27.87%
Return on equity14.04%
Return on assets6.53%
Debt / equity8.54
Current ratio3.34
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Options analytics

Account required
Put / call volume
Put / call open interest
Positioning, not flow
Max pain
ATM implied vol
Nearest strike to spot
Skew (10% OTM)
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
Heaviest put OI

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Earnings

History & consensus estimates
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter $4.54B +21.0%
Next quarter $4.63B +19.2%
Current year $16.92B +18.0%
Next year $18.42B +8.8%

Analyst targets & ownership

Account required
Mean target
High target
Low target
Implied upside
Analyst count
ConsensusNONE
Strong buy / Buy— / —
Hold
Sell / Strong sell— / —
Held by insiders2.08%
Held by institutions93.44%
Institutions holding1.92K
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
SMA 20
SMA 50
SMA 100
SMA 200
EMA 12
EMA 26
EMA 50
RSI (14)
MACD (12,26,9)
Hist —
ATR (14)
Realised vol 30D
Annualised
Bollinger upper
20, 2σ
Bollinger lower
20, 2σ
50 / 200 cross
Trend bias

Options chain

Account required
ExpirySpot 842.87
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
Correlation to SPY
Realised vol 30D
Annualised
Market vol 1Y
SPY, annualised
Max drawdown 1Y
Peak to trough
Max drawdown 5Y
Peak to trough
ATR 14
Average true range
Beta (reported)
0.19
5Y monthly, from filing

Rating changes

545 on file
DateFirm ActionFromTo
Aug 17, 26 Leerink Partners MAINTAINED Market Perform Market Perform
Aug 3, 26 Citigroup MAINTAINED Neutral Neutral
Aug 3, 26 Guggenheim MAINTAINED Buy Buy
Jul 31, 26 RBC Capital MAINTAINED Sector Perform Sector Perform
Jul 31, 26 Morgan Stanley MAINTAINED Equal-Weight Equal-Weight
Jul 31, 26 Cantor Fitzgerald MAINTAINED Overweight Overweight
Jul 31, 26 Wells Fargo MAINTAINED Equal-Weight Equal-Weight
Jul 31, 26 Truist Securities MAINTAINED Buy Buy
Jul 21, 26 Guggenheim MAINTAINED Buy Buy
Jul 9, 26 Piper Sandler MAINTAINED Overweight Overweight
Jul 8, 26 Morgan Stanley MAINTAINED Equal-Weight Equal-Weight
Jul 7, 26 RBC Capital MAINTAINED Sector Perform Sector Perform

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.